Industry executive supports product development and
commercialization within the pharmaceutical and medical technology
CHICAGO--(BUSINESS WIRE)--Mar. 25, 2015--
Today, Navigant (NYSE: NCI) announced that Jeff Evanson has joined the
Life Sciences practice as Managing Director. In his role, Evanson will
assist Life Sciences clients’ growth plans through product and portfolio
strategy, global launches and market development.
Evanson joins Navigant from Novartis (Alcon) where he was the Vice
President and Global Commercial Head of the Pharmaceutical Franchise, a
$4.2 billion division of Novartis (Alcon). During his four and a half
year tenure there, he was responsible for aspects of strategy,
portfolio, global brands, launches and campaigns initially for retina,
then more broadly for all of the pharmaceutical products.
“Jeff is an innovative global business leader who brings a broad range
of experience leading projects and building teams to identify growth
opportunities in competitive environments and leveraging existing
technology to expand into new therapeutic areas,” said Eduardo Schur,
Managing Director and global leader of Navigant’s Life Sciences practice.
Prior to Novartis, Jeff spent 10 years at Medtronic in a variety of
pre-commercialization and post-commercialization roles. He has extensive
experience leading creating Opportunity Assessment through to Global
Launch Plans and Life Cycle Management. These responsibilities allowed
Jeff direct experience with global regulators and payers alike. Jeff
also has experience in Pharmaceutical Sales and Sales Training.
“The pharmaceutical and medical technology industries are expanding at
an incredible pace as innovation continues to fuel new growth. I am
excited to join the team of experts within Navigant’s Life Sciences
practice to strategize with our clients and help them achieve continued
growth and developmental goals,” said Evanson.
Jeff received his MBA from the University of Minnesota and a BA in
Chemistry from the University of St. Thomas in St. Paul Minnesota. He
also has gained key insight and experience as a two-term Board Member of
Gillette Children’s Hospital in St. Paul, Minnesota, from 2008 to 2014.
Navigant (NYSE: NCI) is a specialized, global professional services firm
dedicated to assisting clients in creating and protecting value in the
face of critical business risks and opportunities. Through senior level
engagement with clients, Navigant professionals deliver expert and
advisory work through implementation and business process management
services. The firm combines deep technical expertise in Disputes and
Investigations, Economics, Financial Advisory and Management Consulting,
with business pragmatism to address clients’ needs in highly regulated
industries, including Construction, Energy, Financial Services and
Healthcare. More information about Navigant can be found at navigant.com.
For more information contact:
Navigant Healthcare Marketing